Literature DB >> 23715064

Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply.

Joel M Gelfand, Shuwei Wang, Junko Takeshita, Andrew D Robertson, Gerald G Krueger, Kristina Callis Duffin, Abby S Van Voorhees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23715064      PMCID： PMC3930176          DOI： 10.1001/jamadermatol.2013.2846

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.

Authors:  Christopher E M Griffiths; Bruce E Strober; Peter van de Kerkhof; Vincent Ho; Roseanne Fidelus-Gort; Newman Yeilding; Cynthia Guzzo; Yichuan Xia; Bei Zhou; Shu Li; Lisa T Dooley; Neil H Goldstein; Alan Menter
Journal:  N Engl J Med       Date:  2010-01-14       Impact factor: 91.245

2.  Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

Authors:  Joel M Gelfand; Joy Wan; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Michael B Stierstorfer; Bruce A Brod; Stephen M Schleicher; Bruce F Bebo; Andrea B Troxel; Daniel B Shin; Jane M Steinemann; Jennifer Goldfarb; Howa Yeung; Abby S Van Voorhees
Journal:  Arch Dermatol       Date:  2012-04

3.  Patient-centered online management of psoriasis: a randomized controlled equivalency trial.

Authors:  Cindy J Chambers; Kory K Parsi; Clayton Schupp; April W Armstrong
Journal:  J Am Acad Dermatol       Date:  2011-09-03       Impact factor: 11.527

4.  Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.

Authors:  Howa Yeung; Joy Wan; Abby S Van Voorhees; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Bruce A Brod; Stephen M Schleicher; Bruce F Bebo; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2012-07-28       Impact factor: 11.527

5.  Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

Authors:  J-H Saurat; G Stingl; L Dubertret; K Papp; R G Langley; J-P Ortonne; K Unnebrink; M Kaul; A Camez
Journal:  Br J Dermatol       Date:  2007-11-28       Impact factor: 9.302
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.